<?xml version="1.0" encoding="UTF-8"?>
<jo:ann xmlns:jo="http://boamp.journal-officiel.gouv.fr/XML/3.2.5">
   <DONNEES>
      <EFORMS xmlns:cac="urn:boamp:names:specification:ubl:schema:xsd:CommonAggregateComponents-2"
              xmlns:cbc="urn:boamp:names:specification:ubl:schema:xsd:CommonBasicComponents-2"
              xmlns:efac="http://data.europa.eu/p27/eforms-ubl-extension-aggregate-components/1"
              xmlns:efbc="http://data.europa.eu/p27/eforms-ubl-extension-basic-components/1"
              xmlns:efext="http://data.europa.eu/p27/eforms-ubl-extensions/1"
              xmlns:ext="urn:boamp:names:specification:ubl:schema:xsd:CommonExtensionComponents-2">
         <ContractNotice>
            <ext:UBLExtensions>
               <ext:UBLExtension>
                  <ext:ExtensionContent>
                     <efext:EformsExtension>
                        <efac:NoticeSubType>
                           <cbc:SubTypeCode listName="notice-subtype">16</cbc:SubTypeCode>
                        </efac:NoticeSubType>
                        <efac:Organizations>
                           <efac:Organization>
                              <efac:Company>
                                 <cbc:WebsiteURI>https://ght-leman-mont-blanc.fr</cbc:WebsiteURI>
                                 <cac:PartyIdentification>
                                    <cbc:ID schemeName="organization">ORG-0001</cbc:ID>
                                 </cac:PartyIdentification>
                                 <cac:PartyName>
                                    <cbc:Name languageID="FRA">Centre Hospitalier Alpes Léman (établissement support du GHT Léman  Mont-Blanc)</cbc:Name>
                                 </cac:PartyName>
                                 <cac:PostalAddress>
                                    <cbc:StreetName>558 route de Findrol BP 20500</cbc:StreetName>
                                    <cbc:CityName>CONTAMINE SUR ARVE</cbc:CityName>
                                    <cbc:PostalZone>74130</cbc:PostalZone>
                                    <cbc:CountrySubentityCode listName="nuts">FRK28</cbc:CountrySubentityCode>
                                    <cac:Country>
                                       <cbc:IdentificationCode listName="country">FRA</cbc:IdentificationCode>
                                    </cac:Country>
                                 </cac:PostalAddress>
                                 <cac:PartyLegalEntity>
                                    <cbc:CompanyID>26740084400085</cbc:CompanyID>
                                 </cac:PartyLegalEntity>
                                 <cac:Contact>
                                    <cbc:Name>Cellule juridique des contrats</cbc:Name>
                                    <cbc:Telephone>+33 450822429</cbc:Telephone>
                                    <cbc:ElectronicMail>Achats_publics_ght@ch-alpes-leman.fr</cbc:ElectronicMail>
                                 </cac:Contact>
                              </efac:Company>
                           </efac:Organization>
                           <efac:Organization>
                              <efac:Company>
                                 <cac:PartyIdentification>
                                    <cbc:ID schemeName="organization">ORG-0002</cbc:ID>
                                 </cac:PartyIdentification>
                                 <cac:PartyName>
                                    <cbc:Name languageID="FRA">Tribunal Administratif de Grenoble</cbc:Name>
                                 </cac:PartyName>
                                 <cac:PostalAddress>
                                    <cbc:StreetName>2 place de Verdun BP 1135</cbc:StreetName>
                                    <cbc:CityName>GRENOBLE</cbc:CityName>
                                    <cbc:PostalZone>38022</cbc:PostalZone>
                                    <cbc:CountrySubentityCode listName="nuts">FRK24</cbc:CountrySubentityCode>
                                    <cac:Country>
                                       <cbc:IdentificationCode listName="country">FRA</cbc:IdentificationCode>
                                    </cac:Country>
                                 </cac:PostalAddress>
                                 <cac:PartyLegalEntity>
                                    <cbc:CompanyID>173 800 053 00014</cbc:CompanyID>
                                 </cac:PartyLegalEntity>
                                 <cac:Contact>
                                    <cbc:Telephone>04 76 42 90 00</cbc:Telephone>
                                    <cbc:ElectronicMail>greffe.ta-grenoble@juradm.fr</cbc:ElectronicMail>
                                 </cac:Contact>
                              </efac:Company>
                           </efac:Organization>
                        </efac:Organizations>
                     </efext:EformsExtension>
                  </ext:ExtensionContent>
               </ext:UBLExtension>
            </ext:UBLExtensions>
            <cbc:UBLVersionID>2.3</cbc:UBLVersionID>
            <cbc:CustomizationID>eforms-sdk-1.13</cbc:CustomizationID>
            <cbc:ID schemeName="notice-id">0e8a853f-2009-4877-be0c-f71e3661974a</cbc:ID>
            <cbc:ContractFolderID>1fb8930b-f8a8-45dc-98e8-7589931b7cc2</cbc:ContractFolderID>
            <cbc:IssueDate>2026-05-11+02:00</cbc:IssueDate>
            <cbc:IssueTime>12:30:13.819+02:00</cbc:IssueTime>
            <cbc:VersionID>01</cbc:VersionID>
            <cbc:RegulatoryDomain>32014L0024</cbc:RegulatoryDomain>
            <cbc:NoticeTypeCode listName="competition">cn-standard</cbc:NoticeTypeCode>
            <cbc:NoticeLanguageCode>FRA</cbc:NoticeLanguageCode>
            <cac:ContractingParty>
               <cbc:BuyerProfileURI>https://www.marches-publics.gouv.fr</cbc:BuyerProfileURI>
               <cac:ContractingPartyType>
                  <cbc:PartyTypeCode listName="buyer-legal-type">body-pl</cbc:PartyTypeCode>
               </cac:ContractingPartyType>
               <cac:ContractingActivity>
                  <cbc:ActivityTypeCode listName="authority-activity">health</cbc:ActivityTypeCode>
               </cac:ContractingActivity>
               <cac:Party>
                  <cac:PartyIdentification>
                     <cbc:ID schemeName="organization">ORG-0001</cbc:ID>
                  </cac:PartyIdentification>
               </cac:Party>
            </cac:ContractingParty>
            <cac:TenderingTerms>
               <cac:TendererQualificationRequest>
                  <cac:SpecificTendererRequirement>
                     <cbc:TendererRequirementTypeCode listName="exclusion-grounds-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
                  </cac:SpecificTendererRequirement>
               </cac:TendererQualificationRequest>
            </cac:TenderingTerms>
            <cac:TenderingProcess>
               <cbc:ProcedureCode listName="procurement-procedure-type">open</cbc:ProcedureCode>
               <cac:ProcessJustification>
                  <cbc:ProcessReasonCode listName="accelerated-procedure">false</cbc:ProcessReasonCode>
               </cac:ProcessJustification>
            </cac:TenderingProcess>
            <cac:ProcurementProject>
               <cbc:ID schemeName="InternalID">GHT_Radiopharma_2026</cbc:ID>
               <cbc:Name languageID="FRA">Fourniture de médicaments radiopharmaceutiques</cbc:Name>
               <cbc:Description languageID="FRA">Fourniture de médicaments radiopharmaceutiques
Traceur fluoré spécifique de l'antigène membranaire 
spécifique de la prostate permettant la stadification initiale 
des patients présentant un cancer prostatique à haut risque 
avant un traitement initial à visée curative ET la localisation 
de récidive du cancer de la prostate, chez les patients 
présentant une suspicion de récidive basée sur 
l’augmentation des concentrations sériques d’antigène 
prostatique spécifique (PSA) après un traitement initial à 
visée curative</cbc:Description>
               <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
               <cac:RequestedTenderTotal>
                  <ext:UBLExtensions>
                     <ext:UBLExtension>
                        <ext:ExtensionContent>
                           <efext:EformsExtension>
                              <efbc:FrameworkMaximumAmount currencyID="EUR">410000</efbc:FrameworkMaximumAmount>
                           </efext:EformsExtension>
                        </ext:ExtensionContent>
                     </ext:UBLExtension>
                  </ext:UBLExtensions>
               </cac:RequestedTenderTotal>
               <cac:MainCommodityClassification>
                  <cbc:ItemClassificationCode listName="cpv">33690000</cbc:ItemClassificationCode>
               </cac:MainCommodityClassification>
               <cac:RealizedLocation>
                  <cac:Address>
                     <cbc:CityName>CONTAMINE SUR ARVE</cbc:CityName>
                     <cbc:PostalZone>74130</cbc:PostalZone>
                     <cbc:CountrySubentityCode listName="nuts">FRK28</cbc:CountrySubentityCode>
                     <cac:Country>
                        <cbc:IdentificationCode listName="country">FRA</cbc:IdentificationCode>
                     </cac:Country>
                  </cac:Address>
               </cac:RealizedLocation>
            </cac:ProcurementProject>
            <cac:ProcurementProjectLot>
               <cbc:ID schemeName="Lot">LOT-0001</cbc:ID>
               <cac:TenderingTerms>
                  <cbc:VariantConstraintCode listName="permission">not-allowed</cbc:VariantConstraintCode>
                  <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
                  <cac:CallForTendersDocumentReference>
                     <cbc:ID>https://www.marches-publics.gouv.fr</cbc:ID>
                     <cbc:DocumentType>non-restricted-document</cbc:DocumentType>
                     <cac:Attachment>
                        <cac:ExternalReference>
                           <cbc:URI>https://www.marches-publics.gouv.fr</cbc:URI>
                        </cac:ExternalReference>
                     </cac:Attachment>
                  </cac:CallForTendersDocumentReference>
                  <cac:TendererQualificationRequest>
                     <cac:SpecificTendererRequirement>
                        <cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
                     </cac:SpecificTendererRequirement>
                  </cac:TendererQualificationRequest>
                  <cac:TendererQualificationRequest>
                     <cac:SpecificTendererRequirement>
                        <cbc:TendererRequirementTypeCode listName="reserved-procurement">none</cbc:TendererRequirementTypeCode>
                     </cac:SpecificTendererRequirement>
                  </cac:TendererQualificationRequest>
                  <cac:ContractExecutionRequirement>
                     <cbc:ExecutionRequirementCode listName="reserved-execution">no</cbc:ExecutionRequirementCode>
                  </cac:ContractExecutionRequirement>
                  <cac:ContractExecutionRequirement>
                     <cbc:ExecutionRequirementCode listName="conditions">performance</cbc:ExecutionRequirementCode>
                  </cac:ContractExecutionRequirement>
                  <cac:ContractExecutionRequirement>
                     <cbc:ExecutionRequirementCode listName="einvoicing">required</cbc:ExecutionRequirementCode>
                  </cac:ContractExecutionRequirement>
                  <cac:ContractExecutionRequirement>
                     <cbc:ExecutionRequirementCode listName="ecatalog-submission">not-allowed</cbc:ExecutionRequirementCode>
                  </cac:ContractExecutionRequirement>
                  <cac:ContractExecutionRequirement>
                     <cbc:ExecutionRequirementCode listName="esignature-submission">true</cbc:ExecutionRequirementCode>
                  </cac:ContractExecutionRequirement>
                  <cac:TenderRecipientParty>
                     <cbc:EndpointID>https://www.marches-publics.gouv.fr</cbc:EndpointID>
                  </cac:TenderRecipientParty>
                  <cac:TenderValidityPeriod>
                     <cbc:DurationMeasure unitCode="MONTH">5</cbc:DurationMeasure>
                  </cac:TenderValidityPeriod>
                  <cac:AppealTerms>
                     <cac:PresentationPeriod>
                        <cbc:Description languageID="FRA">11 jours</cbc:Description>
                     </cac:PresentationPeriod>
                     <cac:AppealReceiverParty>
                        <cac:PartyIdentification>
                           <cbc:ID schemeName="organization">ORG-0002</cbc:ID>
                        </cac:PartyIdentification>
                     </cac:AppealReceiverParty>
                  </cac:AppealTerms>
                  <cac:Language>
                     <cbc:ID>FRA</cbc:ID>
                  </cac:Language>
                  <cac:PostAwardProcess>
                     <cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
                     <cbc:ElectronicPaymentUsageIndicator>false</cbc:ElectronicPaymentUsageIndicator>
                  </cac:PostAwardProcess>
               </cac:TenderingTerms>
               <cac:TenderingProcess>
                  <cbc:SubmissionMethodCode listName="esubmission">required</cbc:SubmissionMethodCode>
                  <cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
                  <cac:TenderSubmissionDeadlinePeriod>
                     <cbc:EndDate>2026-06-10+01:00</cbc:EndDate>
                     <cbc:EndTime>12:00:00+01:00</cbc:EndTime>
                  </cac:TenderSubmissionDeadlinePeriod>
                  <cac:AuctionTerms>
                     <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
                  </cac:AuctionTerms>
                  <cac:FrameworkAgreement>
                     <cbc:MaximumOperatorQuantity>1</cbc:MaximumOperatorQuantity>
                     <cac:SubsequentProcessTenderRequirement>
                        <cbc:Name>buyer-categories</cbc:Name>
                     </cac:SubsequentProcessTenderRequirement>
                  </cac:FrameworkAgreement>
                  <cac:ContractingSystem>
                     <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
                  </cac:ContractingSystem>
                  <cac:ContractingSystem>
                     <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
                  </cac:ContractingSystem>
               </cac:TenderingProcess>
               <cac:ProcurementProject>
                  <cbc:Name languageID="FRA">Fourniture de médicaments radiopharmaceutiques</cbc:Name>
                  <cbc:Description languageID="FRA">Fourniture de médicaments radiopharmaceutiques
Traceur fluoré spécifique de l'antigène membranaire 
spécifique de la prostate permettant la stadification initiale 
des patients présentant un cancer prostatique à haut risque 
avant un traitement initial à visée curative ET la localisation 
de récidive du cancer de la prostate, chez les patients 
présentant une suspicion de récidive basée sur 
l’augmentation des concentrations sériques d’antigène 
prostatique spécifique (PSA) après un traitement initial à 
visée curative</cbc:Description>
                  <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
                  <cac:MainCommodityClassification>
                     <cbc:ItemClassificationCode listName="cpv">33690000</cbc:ItemClassificationCode>
                  </cac:MainCommodityClassification>
                  <cac:RealizedLocation>
                     <cac:Address>
                        <cbc:CityName>CONTAMINE SUR ARVE</cbc:CityName>
                        <cbc:PostalZone>74130</cbc:PostalZone>
                        <cbc:CountrySubentityCode listName="nuts">FRK28</cbc:CountrySubentityCode>
                        <cac:Country>
                           <cbc:IdentificationCode listName="country">FRA</cbc:IdentificationCode>
                        </cac:Country>
                     </cac:Address>
                  </cac:RealizedLocation>
                  <cac:PlannedPeriod>
                     <cbc:DurationMeasure unitCode="MONTH">18</cbc:DurationMeasure>
                  </cac:PlannedPeriod>
               </cac:ProcurementProject>
            </cac:ProcurementProjectLot>
         </ContractNotice>
      </EFORMS>
   </DONNEES>
   <GESTION>
      <REFERENCE>
         <IDWEB>26-46957</IDWEB>
         <TYPE_AVIS>
            <FAMILLE>
               <JOUE/>
            </FAMILLE>
            <PERIMETRE>
               <DIRECTIVE-24/>
            </PERIMETRE>
            <NATURE>
               <APPEL_OFFRE>
                  <STANDARD/>
               </APPEL_OFFRE>
            </NATURE>
            <STATUT>
               <INITIAL/>
            </STATUT>
         </TYPE_AVIS>
      </REFERENCE>
      <INDEXATION>
         <SCHEMA>3.2.5</SCHEMA>
         <NOMORGANISME>Centre Hospitalier Alpes Léman (établissement support du GHT Léman Mont-Blanc)</NOMORGANISME>
         <TYPE_PROCEDURE>
            <OUVERT/>
         </TYPE_PROCEDURE>
         <DATE_PUBLICATION>2026-05-12</DATE_PUBLICATION>
         <DATE_LIMITE_REPONSE>2026-06-10T12:00:00+01:00</DATE_LIMITE_REPONSE>
         <DATE_FIN_DIFFUSION>2026-06-10</DATE_FIN_DIFFUSION>
         <DESCRIPTEURS>
            <DESCRIPTEUR>
               <CODE>69</CODE>
               <LIBELLE>Consommables médicaux</LIBELLE>
            </DESCRIPTEUR>
         </DESCRIPTEURS>
         <NATURE_MARCHE>
            <FOURNITURES/>
         </NATURE_MARCHE>
         <DEP_PUBLICATION>74</DEP_PUBLICATION>
         <RESUME_OBJET>Fourniture de médicaments radiopharmaceutiques</RESUME_OBJET>
      </INDEXATION>
   </GESTION>
   <HTML><![CDATA[<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE html
  PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" lang="FR">
   <head>
      <style type="text/css">.fr-h4 { font-weight: 700 !important; margin: 0.5rem 0 0.5rem 0rem!important; font-size: 1.4rem !important; line-height: 2rem !important; } .fr-h5, .fr-h5 + .fr-text--bold { font-weight: 700 !important; margin: 0.5rem 0 0.5rem 0rem !important; font-size: 1.3rem !important; line-height: 2rem !important; } .section { padding: 6px 6px 6px 36px; } .fr-text--bold { font-weight: bold; } .center { text-align: center; }
                </style>
      <title>Avis de marché - Avis n° 26-46957 du 11/05/2026</title>
      <meta name="subject" content="Avis de marché"/>
      <meta name="author"
            content="Direction de l’information légale et administrative (DILA)"/>
      <meta name="description"
            content="Avis de marché - Avis n° 26-46957 du 11/05/2026 sur le site Boamp.fr"/>
   </head>
   <body>
      <div class="center">
         <div class="fr-h4" id="doc_titre">Avis de marché</div>
      </div>
      <div>Département(s) de publication :<span>
            <strong>74</strong>
         </span>
      </div>
      <div>
         <span>Annonce n°</span>
         <strong>26-46957</strong>
      </div>
      <hr/>
      <div id="section_1_d1e5">
         <span class="fr-h5">Section 1 -</span>
         <span class="fr-text--bold">Acheteur</span>
         <div class="section" id="section_1.1_d1e73">
            <span>1.1</span>
            <span class="fr-text--bold">Acheteur</span>
            <div class="section">
               <span class="fr-text--bold">Nom officiel</span>
               <span>:</span>
               <span>Centre Hospitalier Alpes Léman (établissement support du GHT Léman Mont-Blanc)</span>
            </div>
            <div class="section">
               <span class="fr-text--bold">Forme juridique de l’acheteur</span>
               <span>:</span>
               <span>Organisme de droit public</span>
            </div>
            <div class="section">
               <span class="fr-text--bold">Activité du pouvoir adjudicateur</span>
               <span>:</span>
               <span>Santé</span>
            </div>
         </div>
      </div>
      <div id="section_2_d1e5">
         <span class="fr-h5">Section 2 -</span>
         <span class="fr-text--bold">Procédure</span>
         <div class="section" id="section_2.1_d1e96">
            <span>2.1</span>
            <span class="fr-text--bold">Procédure</span>
            <div class="section">
               <span class="fr-text--bold">Titre</span>
               <span>:</span>
               <span>Fourniture de médicaments radiopharmaceutiques</span>
            </div>
            <div class="section">
               <span class="fr-text--bold">Description</span>
               <span>:</span>
               <span>Fourniture de médicaments radiopharmaceutiques Traceur fluoré spécifique de l'antigène membranaire spécifique de la prostate permettant la stadification initiale des patients présentant un cancer prostatique à haut risque avant un traitement initial à visée curative ET la localisation de récidive du cancer de la prostate, chez les patients présentant une suspicion de récidive basée sur l’augmentation des concentrations sériques d’antigène prostatique spécifique (PSA) après un traitement initial à visée curative</span>
            </div>
            <div class="section">
               <span class="fr-text--bold">Identifiant de la procédure</span>
               <span>:</span>
               <span>1fb8930b-f8a8-45dc-98e8-7589931b7cc2</span>
            </div>
            <div class="section">
               <span class="fr-text--bold">Identifiant interne</span>
               <span>:</span>
               <span>GHT_Radiopharma_2026</span>
            </div>
            <div class="section">
               <span class="fr-text--bold">Type de procédure</span>
               <span>:</span>
               <span>Ouverte</span>
            </div>
            <div class="section">
               <span class="fr-text--bold">La procédure est accélérée</span>
               <span>:</span>
               <span class="fr-text--bold">non</span>
            </div>
            <div class="section" id="section_2.1.1_d1e96">
               <span>2.1.1</span>
               <span class="fr-text--bold">Objet</span>
               <div class="section">
                  <span class="fr-text--bold">Nature du marché</span>
                  <span>:</span>
                  <span>Fournitures</span>
               </div>
               <div class="section">
                  <span class="fr-text--bold">Nomenclature principale</span>
                  <span/>
                  <span>(</span>
                  <span>cpv</span>
                  <span>):</span>
                  <span>33690000</span>
                  <span/>
                  <span>Médicaments divers</span>
               </div>
            </div>
            <div class="section" id="section_2.1.2_d1e116">
               <span>2.1.2</span>
               <span class="fr-text--bold">Lieu d’exécution</span>
               <div class="section">
                  <span class="fr-text--bold">Ville</span>
                  <span>:</span>
                  <span>CONTAMINE SUR ARVE</span>
               </div>
               <div class="section">
                  <span class="fr-text--bold">Code postal</span>
                  <span>:</span>
                  <span>74130</span>
               </div>
               <div class="section">
                  <span class="fr-text--bold">Subdivision pays (NUTS)</span>
                  <span>:</span>
                  <span>Haute-Savoie</span>
                  <span/>
                  <span>(</span>
                  <span>FRK28</span>
                  <span>)</span>
               </div>
               <div class="section">
                  <span class="fr-text--bold">Pays</span>
                  <span>:</span>
                  <span>France</span>
               </div>
            </div>
            <div class="section" id="section_2.1.3_d1e96">
               <span>2.1.3</span>
               <span class="fr-text--bold">Valeur</span>
               <div class="section">
                  <span class="fr-text--bold">Valeur maximale de l’accord-cadre</span>
                  <span>:</span>
                  <span>410,000</span>
                  <span/>
                  <span class="fr-text--bold">Euro</span>
               </div>
            </div>
            <div class="section" id="section_2.1.4_d1e96">
               <span>2.1.4</span>
               <span class="fr-text--bold">Informations générales</span>
               <div class="section">
                  <span class="fr-text--bold">Base juridique</span>
                  <span>:</span>
               </div>
               <div class="section">
                  <span>Directive 2014/24/UE</span>
               </div>
            </div>
         </div>
      </div>
      <div id="section_5_d1e5">
         <span class="fr-h5">Section 5 -</span>
         <span class="fr-text--bold">Lot</span>
         <div class="section" id="section_5.1_d1e124">
            <span>5.1</span>
            <span class="fr-text--bold">Identifiant technique du lot</span>
            <span>:</span>
            <span>LOT-0001</span>
            <div class="section">
               <span class="fr-text--bold">Titre</span>
               <span>:</span>
               <span>Fourniture de médicaments radiopharmaceutiques</span>
            </div>
            <div class="section">
               <span class="fr-text--bold">Description</span>
               <span>:</span>
               <span>Fourniture de médicaments radiopharmaceutiques Traceur fluoré spécifique de l'antigène membranaire spécifique de la prostate permettant la stadification initiale des patients présentant un cancer prostatique à haut risque avant un traitement initial à visée curative ET la localisation de récidive du cancer de la prostate, chez les patients présentant une suspicion de récidive basée sur l’augmentation des concentrations sériques d’antigène prostatique spécifique (PSA) après un traitement initial à visée curative</span>
            </div>
            <div class="section" id="section_5.1.1_d1e199">
               <span>5.1.1</span>
               <span class="fr-text--bold">Objet</span>
               <div class="section">
                  <span class="fr-text--bold">Nature du marché</span>
                  <span>:</span>
                  <span>Fournitures</span>
               </div>
               <div class="section">
                  <span class="fr-text--bold">Nomenclature principale</span>
                  <span/>
                  <span>(</span>
                  <span>cpv</span>
                  <span>):</span>
                  <span>33690000</span>
                  <span/>
                  <span>Médicaments divers</span>
               </div>
            </div>
            <div class="section" id="section_5.1.2_d1e209">
               <span>5.1.2</span>
               <span class="fr-text--bold">Lieu d’exécution</span>
               <div class="section">
                  <span class="fr-text--bold">Ville</span>
                  <span>:</span>
                  <span>CONTAMINE SUR ARVE</span>
               </div>
               <div class="section">
                  <span class="fr-text--bold">Code postal</span>
                  <span>:</span>
                  <span>74130</span>
               </div>
               <div class="section">
                  <span class="fr-text--bold">Subdivision pays (NUTS)</span>
                  <span>:</span>
                  <span>Haute-Savoie</span>
                  <span/>
                  <span>(</span>
                  <span>FRK28</span>
                  <span>)</span>
               </div>
               <div class="section">
                  <span class="fr-text--bold">Pays</span>
                  <span>:</span>
                  <span>France</span>
               </div>
               <div class="section">
                  <span class="fr-text--bold">Informations complémentaires</span>
                  <span>:</span>
                  <span/>
               </div>
            </div>
            <div class="section" id="section_5.1.3_d1e218">
               <span>5.1.3</span>
               <span class="fr-text--bold">Durée estimée</span>
               <div class="section">
                  <span class="fr-text--bold">Durée</span>
                  <span>:</span>
                  <span>18</span>
                  <span/>
                  <span class="fr-text--bold">Mois</span>
               </div>
            </div>
            <div class="section" id="section_5.1.6_d1e124">
               <span>5.1.6</span>
               <span class="fr-text--bold">Informations générales</span>
               <div class="section">
                  <span class="fr-text--bold">Participation réservée</span>
                  <span>:</span>
                  <span>La participation n’est pas réservée.</span>
               </div>
               <div class="section">
                  <span>Projet de passation de marché non financé par des fonds de l’UE</span>
               </div>
               <div class="section">
                  <span class="fr-text--bold">Le marché relève de l’accord sur les marchés publics (AMP)</span>
                  <span>:</span>
                  <span class="fr-text--bold">oui</span>
               </div>
            </div>
            <div class="section" id="section_5.1.11_d1e125">
               <span>5.1.11</span>
               <span class="fr-text--bold">Documents de marché</span>
               <div class="section">
                  <span class="fr-text--bold">Adresse des documents de marché</span>
                  <span>:</span>
                  <span>https://www.marches-publics.gouv.fr</span>
               </div>
            </div>
            <div class="section" id="section_5.1.12_d1e124">
               <span>5.1.12</span>
               <span class="fr-text--bold">Conditions du marché public</span>
               <div class="section">
                  <span class="fr-text--bold">Conditions de présentation</span>
                  <span>:</span>
                  <div class="section">
                     <span class="fr-text--bold">Présentation par voie électronique</span>
                     <span>:</span>
                     <span>Requise</span>
                  </div>
                  <div class="section">
                     <span class="fr-text--bold">Adresse de présentation</span>
                     <span>:</span>
                     <span>https://www.marches-publics.gouv.fr</span>
                  </div>
                  <div class="section">
                     <span class="fr-text--bold">Langues dans lesquelles les offres ou demandes de participation peuvent être présentées</span>
                     <span>:</span>
                     <span>français</span>
                  </div>
                  <div class="section">
                     <span class="fr-text--bold">Catalogue électronique</span>
                     <span>:</span>
                     <span>Non autorisée</span>
                  </div>
                  <div class="section">
                     <span class="fr-text--bold">La signature ou le cachet électronique avancé(e) ou qualifié(e) [au sens du règlement (UE) № 910/2014] est requis(e)</span>
                  </div>
                  <div class="section">
                     <span class="fr-text--bold">Variantes</span>
                     <span>:</span>
                     <span>Non autorisée</span>
                  </div>
                  <div class="section">
                     <span class="fr-text--bold">Date limite de réception des offres</span>
                     <span>:</span>
                     <span>10/06/2026</span>
                     <span/>
                     <span>à 12:00</span>
                  </div>
                  <div class="section">
                     <span class="fr-text--bold">Date limite de validité de l’offre</span>
                     <span>:</span>
                     <span>5</span>
                     <span/>
                     <span class="fr-text--bold">Mois</span>
                  </div>
               </div>
               <div class="section">
                  <span class="fr-text--bold">Conditions du marché</span>
                  <span>:</span>
                  <div class="section">
                     <span class="fr-text--bold">Le marché doit être exécuté dans le cadre de programmes d’emplois protégés</span>
                     <span>:</span>
                     <span>Non</span>
                  </div>
                  <div class="section">
                     <span class="fr-text--bold">Facturation en ligne</span>
                     <span>:</span>
                     <span>Requise</span>
                  </div>
                  <div class="section">
                     <span class="fr-text--bold">La commande en ligne sera utilisée</span>
                     <span>:</span>
                     <span class="fr-text--bold">non</span>
                  </div>
                  <div class="section">
                     <span class="fr-text--bold">Le paiement en ligne sera utilisé</span>
                     <span>:</span>
                     <span class="fr-text--bold">non</span>
                  </div>
               </div>
            </div>
            <div class="section" id="section_5.1.15_d1e180">
               <span>5.1.15</span>
               <span class="fr-text--bold">Techniques</span>
               <div class="section">
                  <span class="fr-text--bold">Accord-cadre</span>
                  <span>:</span>
                  <div class="section">
                     <span>Accord-cadre, sans remise en concurrence</span>
                  </div>
                  <div class="section">
                     <span class="fr-text--bold">Nombre maximal de participants</span>
                     <span>:</span>
                     <span>1</span>
                  </div>
               </div>
               <div class="section">
                  <span class="fr-text--bold">Informations sur le système d’acquisition dynamique</span>
                  <span>:</span>
                  <div class="section">
                     <span>Pas de système d’acquisition dynamique</span>
                  </div>
               </div>
            </div>
            <div class="section" id="section_5.1.16_d1e125">
               <span>5.1.16</span>
               <span class="fr-text--bold">Informations complémentaires, médiation et réexamen</span>
               <div class="section">
                  <span class="fr-text--bold">Organisation chargée des procédures de recours</span>
                  <span>:</span>
                  <span>Tribunal Administratif de Grenoble</span>
                  <span/>
               </div>
               <div class="section">
                  <span class="fr-text--bold">Informations relatives aux délais de recours</span>
                  <span>:</span>
                  <span>11 jours</span>
               </div>
            </div>
         </div>
      </div>
      <div id="section_8_d1e5">
         <span class="fr-h5">Section 8 -</span>
         <span class="fr-text--bold">Organisations</span>
         <div class="section" id="section_8.1_d1e14">
            <span>8.1</span>
            <span>ORG-0001</span>
            <div class="section">
               <span class="fr-text--bold">Nom officiel</span>
               <span>:</span>
               <span>Centre Hospitalier Alpes Léman (établissement support du GHT Léman Mont-Blanc)</span>
            </div>
            <div class="section">
               <span class="fr-text--bold">Numéro d’enregistrement</span>
               <span>:</span>
               <span>26740084400085</span>
            </div>
            <div class="section">
               <span class="fr-text--bold">Adresse postale</span>
               <span>:</span>
               <span>558 route de Findrol BP 20500</span>
               <span/>
               <span/>
               <span/>
               <span/>
            </div>
            <div class="section">
               <span class="fr-text--bold">Ville</span>
               <span>:</span>
               <span>CONTAMINE SUR ARVE</span>
            </div>
            <div class="section">
               <span class="fr-text--bold">Code postal</span>
               <span>:</span>
               <span>74130</span>
            </div>
            <div class="section">
               <span class="fr-text--bold">Subdivision pays (NUTS)</span>
               <span>:</span>
               <span>Haute-Savoie</span>
               <span/>
               <span>(</span>
               <span>FRK28</span>
               <span>)</span>
            </div>
            <div class="section">
               <span class="fr-text--bold">Pays</span>
               <span>:</span>
               <span>France</span>
            </div>
            <div class="section">
               <span class="fr-text--bold">Point de contact</span>
               <span>:</span>
               <span>Cellule juridique des contrats</span>
            </div>
            <div class="section">
               <span class="fr-text--bold">Adresse électronique</span>
               <span>:</span>
               <span>Achats_publics_ght@ch-alpes-leman.fr</span>
            </div>
            <div class="section">
               <span class="fr-text--bold">Téléphone</span>
               <span>:</span>
               <span>+33 450822429</span>
            </div>
            <div class="section">
               <span class="fr-text--bold">Adresse internet</span>
               <span>:</span>
               <span>https://ght-leman-mont-blanc.fr</span>
            </div>
            <div class="section">
               <span class="fr-text--bold">Profil de l’acheteur</span>
               <span>:</span>
               <span>https://www.marches-publics.gouv.fr</span>
            </div>
            <div class="section">
               <span class="fr-text--bold">Rôles de cette organisation</span>
               <span>:</span>
               <div class="section">
                  <span class="fr-text--bold">Acheteur</span>
               </div>
            </div>
         </div>
         <div class="section" id="section_8.1_d1e38">
            <span>8.1</span>
            <span>ORG-0002</span>
            <div class="section">
               <span class="fr-text--bold">Nom officiel</span>
               <span>:</span>
               <span>Tribunal Administratif de Grenoble</span>
            </div>
            <div class="section">
               <span class="fr-text--bold">Numéro d’enregistrement</span>
               <span>:</span>
               <span>173 800 053 00014</span>
            </div>
            <div class="section">
               <span class="fr-text--bold">Adresse postale</span>
               <span>:</span>
               <span>2 place de Verdun BP 1135</span>
               <span/>
               <span/>
               <span/>
               <span/>
            </div>
            <div class="section">
               <span class="fr-text--bold">Ville</span>
               <span>:</span>
               <span>GRENOBLE</span>
            </div>
            <div class="section">
               <span class="fr-text--bold">Code postal</span>
               <span>:</span>
               <span>38022</span>
            </div>
            <div class="section">
               <span class="fr-text--bold">Subdivision pays (NUTS)</span>
               <span>:</span>
               <span>Isère</span>
               <span/>
               <span>(</span>
               <span>FRK24</span>
               <span>)</span>
            </div>
            <div class="section">
               <span class="fr-text--bold">Pays</span>
               <span>:</span>
               <span>France</span>
            </div>
            <div class="section">
               <span class="fr-text--bold">Adresse électronique</span>
               <span>:</span>
               <span>greffe.ta-grenoble@juradm.fr</span>
            </div>
            <div class="section">
               <span class="fr-text--bold">Téléphone</span>
               <span>:</span>
               <span>04 76 42 90 00</span>
            </div>
            <div class="section">
               <span class="fr-text--bold">Rôles de cette organisation</span>
               <span>:</span>
               <div class="section">
                  <span class="fr-text--bold">Organisation chargée des procédures de recours</span>
               </div>
            </div>
         </div>
      </div>
      <div class="section">
         <span class="fr-text--bold">Informations relatives à l’avis</span>
         <div class="section">
            <span class="fr-text--bold">Identifiant/version de l’avis</span>
            <span>:</span>
            <span>0e8a853f-2009-4877-be0c-f71e3661974a</span>
            <span/>
            <span>-</span>
            <span>01</span>
         </div>
         <div class="section">
            <span class="fr-text--bold">Type de formulaire</span>
            <span>:</span>
            <span>Mise en concurrence</span>
         </div>
         <div class="section">
            <span class="fr-text--bold">Type d’avis</span>
            <span>:</span>
            <span>Avis de marché ou de concession – régime ordinaire</span>
         </div>
         <div class="section">
            <span class="fr-text--bold">Date d’envoi de l’avis</span>
            <span>:</span>
            <span>11/05/2026</span>
            <span/>
            <span>à 12:30</span>
         </div>
         <div class="section">
            <span class="fr-text--bold">Langues dans lesquelles l’avis en question est officiellement disponible</span>
            <span>:</span>
            <span>français</span>
            <span/>
            <span/>
         </div>
      </div>
      <hr/>
      <div>
         <span class="fr-text--bold">Date d'envoi du présent avis à la publication : </span>11/05/2026</div>
   </body>
</html>
]]></HTML>
   <HTMLSYNTHESE><![CDATA[<!DOCTYPE HTML>
<html>
   <head>
      <meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
   </head>
   <body>
      <h3>L’essentiel du marché</h3>
      <ul>
         <li><span>Acheteur(s) : </span><ul>
               <li><span class="fr-text--bold">Centre Hospitalier Alpes Léman (établissement support du GHT Léman Mont-Blanc) : </span><ul>
                     <li><span class="fr-text--bold">Adresse : </span>558 route de Findrol BP 20500CONTAMINE SUR ARVE74130FRK28FRA</li>
                     <li><span class="fr-text--bold">Point(s) de contact : </span>Cellule juridique des contrats</li>
                     <li><span class="fr-text--bold">Téléphone : </span>+33 450822429</li>
                     <li><span class="fr-text--bold">Courriel : </span>Achats_publics_ght@ch-alpes-leman.fr</li>
                     <li><span class="fr-text--bold">Adresse internet : </span><a href="https://ght-leman-mont-blanc.fr" target="_blank" title="Aller sur la page https://ght-leman-mont-blanc.fr - nouvelle fenêtre"><span>https://ght-leman-mont-blanc.fr</span></a></li>
                     <li><span class="fr-text--bold">Adresse internet du profil d'acheteur : </span><a href="https://www.marches-publics.gouv.fr" target="_blank" title="Aller sur la page https://www.marches-publics.gouv.fr - nouvelle fenêtre"><span>https://www.marches-publics.gouv.fr</span></a></li>
                  </ul>
               </li>
            </ul>
         </li>
         <li><span class="fr-text--bold">Titre du marché : </span>Fourniture de médicaments radiopharmaceutiques</li>
         <li><span class="fr-text--bold">Objet du marché : </span>Fourniture de médicaments radiopharmaceutiques Traceur fluoré spécifique de l'antigène
            membranaire spécifique de la prostate permettant la stadification initiale des patients
            présentant un cancer prostatique à haut risque avant un traitement initial à visée
            curative ET la localisation de récidive du cancer de la prostate, chez les patients
            présentant une suspicion de récidive basée sur l’augmentation des concentrations sériques
            d’antigène prostatique spécifique (PSA) après un traitement initial à visée curative</li>
         <li><span class="fr-text--bold">Renseignements relatifs aux lots :</span><ul>
               <li><span class="fr-text--bold">Lot 1 : </span>Fourniture de médicaments radiopharmaceutiques</li>
            </ul>
         </li>
      </ul>
   </body>
</html>]]></HTMLSYNTHESE>
</jo:ann>
